Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ximoprofen is a novel anti-inflammatory compound for the study of spondylitis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 373.00 | |
5 mg | In stock | $ 896.00 | |
10 mg | In stock | $ 1,230.00 | |
25 mg | In stock | $ 1,820.00 | |
50 mg | In stock | $ 2,450.00 | |
100 mg | In stock | $ 3,290.00 |
Description | Ximoprofen is a novel anti-inflammatory compound for the study of spondylitis. |
In vivo | The aim of the study was to evaluate the efficacy of different daily dosages of Ximoprofen in patients with active ankylosing spondylitis. For 2 weeks 5 parallel groups were studied: placebo and Ximoprofen at 5, 10, 20, and 30 mg daily. Response to treatment was defined as an improvement in pain (VAS 100 mm) of at least 50% during the study. At the end of the study, the percentage of responders was higher in the Ximoprofen groups (54%, 41%, 53%, 56% in the 5, 10, 20, and 30 mg groups, respectively) than in the placebo group (21%). The clearest dose-related effect of Ximoprofen observed occurred after one week of treatment. This study 1/confirms the efficacy of Ximoprofen at a 30 mg daily dosage, 2/shows the persistence of this efficacy at lower dosages, 3/suggests that ankylosing spondylitis is a sensitive and relevant human model to assess NSAIDs at an early stage of clinical evaluation.[1] |
Synonyms | Ximoprofeno, Ximoprofenum |
Molecular Weight | 261.32 |
Formula | C15H19NO3 |
CAS No. | 56187-89-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (191.34 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ximoprofen 56187-89-4 Others Ximoprofeno Ximoprofenum inhibitor inhibit